fda warning letters compounded tirzepatide 2024 2025 🚨 Moves to Permanently Shut Down GLP-1s The FDA is taking steps to eliminate large-scale compounding of GLP-1 medications like semaglutide and tirzepatide, signaling a major shift in how these Out of Shortage, Into Controversy:
Description
Whether youre accessing brand-name Mounjaro or Zepbound, or choosing more affordable compounded tirzepatide, the dosing principles remain constant
Researchers in 2026 should evaluate both compounds against current Phase 3 data as it becomes available
These concentrations demand extreme care
The company has secured a regulatory priority voucher that can accelerate review time, potentially giving the pill an edge as more oral competitors move through the pipeline
What a great product
Some people do not lose any weight until they reach 5 mg or even 7.5 mg
